Literature DB >> 20126842

Hypogonadism after traumatic brain injury.

Alexandre Hohl1, Tânia Longo Mazzuco, Marisa Helena César Coral, Marcelo Schwarzbold, Roger Walz.   

Abstract

Traumatic brain injury (TBI) is the most common cause of death and disability in young adults. Post-TBI neuroendocrine disorders have been increasingly acknowledged in recent years due to their potential contribution to morbidity and, probably, to mortality after trauma. Marked alterations of the hypothalamic-pituitary axis during the post-TBI acute and chronic phases have been reported. Prospective and longitudinal studies have shown that some abnormalities are transitory. On the other hand, there is a high frequency (15% to 68%) of pituitary hormone deficiency among TBI survivors in a long term setting. Post-TBI hypogonadism is a common finding after cranial trauma, and it is predicted to develop in 16% of the survivors in the long term. Post-TBI hypogonadism has been associated with adverse results in the acute and chronic phases after injury. These data reinforce the need for identification of hormonal deficiencies and their proper treatment, in order to optimize patient recovery, improve their life quality, and avoid the negative consequences of non-treated hypogonadism in the long term.

Entities:  

Mesh:

Year:  2009        PMID: 20126842     DOI: 10.1590/s0004-27302009000800003

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  3 in total

Review 1.  Hypogonadism and neurological diseases.

Authors:  Abdulaziz Alsemari
Journal:  Neurol Sci       Date:  2013-01-05       Impact factor: 3.307

2.  Pituitary dysfunction in traumatic brain injury: Is evaluation in the acute phase worthwhile?

Authors:  Pradip P Dalwadi; Nikhil M Bhagwat; Parimal S Tayde; Ameya S Joshi; Premlata K Varthakavi
Journal:  Indian J Endocrinol Metab       Date:  2017 Jan-Feb

3.  Luteinizing Hormone and Testosterone Levels during Acute Phase of Severe Traumatic Brain Injury: Prognostic Implications for Adult Male Patients.

Authors:  Alexandre Hohl; Fernando Areas Zanela; Gabriela Ghisi; Marcelo Fernando Ronsoni; Alexandre Paim Diaz; Marcelo Liborio Schwarzbold; Alcir Luiz Dafre; Benjamin Reddi; Kátia Lin; Felipe Dal Pizzol; Roger Walz
Journal:  Front Endocrinol (Lausanne)       Date:  2018-02-13       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.